#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Ovarian cancer Dementia Alzheimer's type Colorectal cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Malignant melanoma Non-small cell lung cancer metastatic Asthma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Fatty acid oxidation disorder Cortical dysplasia Hypereosinophilic syndrome Mucopolysaccharidosis I Langerhans cell sarcoma Ischaemic stroke Meningococcal immunisation C3 glomerulopathy Multifocal motor neuropathy Marfan's syndrome Adenovirus infection Breast cancer Anti-neutrophil cytoplasmic antibody positive vasculitis Fibrosarcoma Adrenogenital syndrome More trials…

    Learn about Rare Diseases

    Wiskott-Aldrich syndrome – Life with Disease Kearns-Sayre syndrome – Treatment Adrenogenital syndrome – Treatment Mucous membrane pemphigoid – Life with Disease Haemolytic uraemic syndrome – Diagnostics Lymphangiosarcoma – Diagnostics Mucopolysaccharidosis I Undifferentiated sarcoma – Life with Disease Breast angiosarcoma metastatic – Life with Disease Rosai-Dorfman syndrome – Trials in Disease More diseases…
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Padeliporfin Imiquimod Clavulanic Acid Damoctocog Alfa Pegol Methylprednisolone Florbetapir (18F) Human Albumin Solution Satralizumab 64CU-PSMA I&T Anidulafungin Sym024 Doxycycline Hyclate Alks 2680 TUVATEXIB Clomifene Citrate Verapamil Hydrochloride Oregovomab Hydroxocobalamin Pelareorep Sodium Nitroprusside Dihydrate More therapies…

    Learn about Your Condition

    Myxofibrosarcoma Petit mal epilepsy Food allergy Congenital aplastic anaemia Arthroscopy Blood disorder High-grade B-cell lymphoma Adenocarcinoma of colon Retroperitoneal fibrosis Cachexia Anal cancer Extraskeletal ossification Pulmonary sarcoidosis Obsessive-compulsive disorder Thyroid cancer metastatic More diseases…
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Halle (Saale)

  • Study Comparing Teclistamab, Talquetamab, and Drug Combination for Patients with Newly Diagnosed Multiple Myeloma Not Suitable for Stem Cell Transplant

    Recruiting

    3 1 1 1
    Investigated drugs:
    • Dexamethasone Ph. Eur.
    • Talquetamab
    • Daratumumab
    Austria Belgium Czechia Denmark France Germany +8
  • Study on the Effects of Cyclosporine A in Patients with Takotsubo Syndrome

    Recruiting

    2 1 1
    Investigated diseases:
    • Stress cardiomyopathy
    Investigated drugs:
    • Ciclosporin
    • Sodium Chloride
    Germany
  • Study Comparing OSE2101 and Docetaxel for Patients with Metastatic Non-Small Cell Lung Cancer After Immunotherapy Resistance

    Recruiting

    3 1 1 1
    Investigated drugs:
    • D-Ala-Lys-Cha-Val-Ala-Ala-Trp-Thr-Leu-Lys-Ala-Ala-D-Ala
    • Mps-102
    • Mps-103
    Belgium France Germany Greece Hungary Italy +5
  • Study on Adding Navtemadlin to Ruxolitinib for Patients with Myelofibrosis and Suboptimal Response to Ruxolitinib

    Recruiting

    3 1 1
    Investigated drugs:
    • Navtemadlin
    • Loperamide Hydrochloride
    • Ondansetron
    Austria Belgium Croatia Czechia France Germany +7
  • Study on Bortezomib and Drug Combination for Children with High-Risk Relapsed Acute Lymphoblastic Leukemia (ALL)

    Recruiting

    2 1 1 1
    Investigated drugs:
    • Pegaspargase
    • Bortezomib
    • Dexamethasone
    Austria Belgium Czechia Finland France Germany +5
  • Study Comparing Bomedemstat and Hydroxycarbamide for Patients with Essential Thrombocythemia

    Recruiting

    3 1 1
    Investigated drugs:
    • Bomedemstat
    • Hydroxycarbamide
    Austria Denmark France Germany Hungary Italy +3
Previous Page
1 … 12 13 14 15 16 … 53
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Carboplatin Cisplatin Cyclophosphamide Pembrolizumab Etoposide Cytarabine Rituximab Vincristine Sulfate Azacitidine Venetoclax Doxorubicin Hydrochloride Docetaxel Prednisone Atezolizumab Pemetrexed Busulfan Fluorouracil Oxaliplatin Dexamethasone Thiotepa Methotrexate Prednisolone Paclitaxel Daunorubicin Ifosfamide Durvalumab Daunorubicin Hydrochloride Obinutuzumab Ruxolitinib Lenalidomide Show more

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

Acoustic neuroma Actinic keratosis Acute graft versus host disease Acute graft versus host disease in intestine Acute kidney injury Acute lymphocytic leukaemia Acute lymphocytic leukaemia recurrent Acute lymphocytic leukaemia refractory Acute myeloid leukaemia Acute myeloid leukaemia recurrent Acute myeloid leukaemia refractory Acute respiratory distress syndrome Adenocarcinoma gastric Adenocarcinoma pancreas Adult T-cell lymphoma/leukaemia refractory Allogenic stem cell transplantation Alopecia areata Anaemia Anaplastic large cell lymphoma T- and null-cell types Arteriosclerosis Asthma Atrial fibrillation Atypical teratoid/rhabdoid tumour of CNS Autonomic nervous system imbalance B-cell lymphoma B-cell small lymphocytic lymphoma B-cell type acute leukaemia B-cell unclassifiable lymphoma high grade Basal cell carcinoma Bladder cancer Bladder transitional cell carcinoma Breast cancer Breast cancer female Breast cancer male Breast cancer recurrent Breast cancer stage I Breast cancer stage II Breast cancer stage III Bronchiectasis Cardiac failure Cardiac function disturbance postoperative Cardiomyopathy Central nervous system lymphoma Central nervous system melanoma Cerebrovascular accident prophylaxis Cholangiocarcinoma Chronic cutaneous lupus erythematosus Chronic graft versus host disease Chronic inflammatory demyelinating polyradiculoneuropathy Chronic kidney disease Chronic lymphocytic leukaemia Chronic lymphocytic leukaemia recurrent Chronic myeloid leukaemia Chronic myeloid leukaemia (in remission) Chronic myelomonocytic leukaemia Chronic obstructive pulmonary disease Chronic spontaneous urticaria Clear cell renal cell carcinoma Coeliac disease Colitis ulcerative Colon cancer stage II Colorectal adenocarcinoma Colorectal cancer metastatic Colorectal cancer stage III Colorectal cancer stage IV Contraception Cough Craniocerebral injury Crohn's disease Cutaneous lupus erythematosus Cystic fibrosis Deafness neurosensory Dermatitis atopic Diabetic retinal oedema Diffuse large B-cell lymphoma Diffuse large B-cell lymphoma stage IV Double hit lymphoma Dysmenorrhoea Ependymoma Epstein-Barr virus associated lymphoma Essential thrombocythaemia Ewing's sarcoma Extranodal marginal zone B-cell lymphoma (MALT type) Fallopian tube cancer Follicle centre lymphoma follicular grade I, II - III Follicular lymphoma Gastrointestinal melanoma Gastrooesophageal cancer Glycogen storage disease type II Graft versus host disease Head and neck cancer metastatic Head and neck cancer stage III Head and neck cancer stage IV Hepatic cirrhosis Hepatocellular carcinoma HER2 positive breast cancer HER2 positive gastric cancer Herpes simplex Hidradenitis High grade B-cell lymphoma Burkitt-like lymphoma High grade B-cell lymphoma Burkitt-like lymphoma recurrent High-grade B-cell lymphoma Hormone receptor positive breast cancer Hormone receptor positive HER2 negative breast cancer Hormone-dependent prostate cancer Hot flush Human epidermal growth factor receptor negative Idiopathic pulmonary fibrosis Immunoglobulin G4 related disease Indolent systemic mastocytosis Infertility male Intervertebral disc degeneration Ischaemic stroke K-ras gene mutation Left ventricular hypertrophy Leukaemia recurrent Lower respiratory tract infection Lung neoplasm malignant Lymphatic malformation Magnetic resonance imaging Malignant melanoma Malignant melanoma of eyelid Malignant melanoma stage III Malignant melanoma stage IV Malignant peritoneal neoplasm Mantle cell lymphoma Marginal zone lymphoma Marginal zone lymphoma refractory Medulloblastoma Melanoma recurrent Metastatic malignant melanoma Myelodysplastic syndrome Myelofibrosis Nasopharyngeal cancer Neoplasm malignant Nephroblastoma Neuroblastoma Neurodermatitis Neuroendocrine tumour Nodal marginal zone B-cell lymphoma Non-Hodgkin's lymphoma Non-Hodgkin's lymphoma unspecified histology aggressive Non-small cell lung cancer Non-small cell lung cancer metastatic Non-small cell lung cancer stage II Non-small cell lung cancer stage III Non-small cell lung cancer stage IIIA Non-small cell lung cancer stage IIIB Non-small cell lung cancer stage IV Obesity Oesophageal adenocarcinoma Osteoarthritis Ovarian cancer Overweight Pancreatic carcinoma Pancreatic carcinoma metastatic Pancreatic carcinoma stage IV Pancreatic neoplasm Pancreatic neuroendocrine tumour Peripheral T-cell lymphoma unspecified PIK3CA related overgrowth spectrum PIK3CA-activated mutation Plasma cell myeloma Polycythaemia vera Polyneuropathy Primary mediastinal large B-cell lymphoma Primary myelofibrosis Procedural haemorrhage Prostate cancer metastatic Psoriasis Pulmonary arterial hypertension Pulmonary hypertension Pyoderma gangrenosum Rectal cancer stage II Renal cell carcinoma Renal failure Retinal artery occlusion Rhabdomyosarcoma Secondary progressive multiple sclerosis Small cell lung cancer Small cell lung cancer extensive stage Small cell lung cancer metastatic Spinal cord injury cervical Splenic marginal zone lymphoma Squamous cell carcinoma of lung Squamous cell carcinoma of skin Stress cardiomyopathy Subacute cutaneous lupus erythematosus Systemic candida Systemic scleroderma Thalassaemia Thermal burn Thrombocytosis Thrombotic microangiopathy Transient ischaemic attack Transitional cell carcinoma Triple negative breast cancer Trisomy 21 Vaginal infection Vascular malformation Waldenstrom's macroglobulinaemia

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!